Patent · US Active

Composition for detecting undifferentiated human pluripotent stem cell, monoclonal antibody 6-1 and use thereof

US9752190B2 · kind B2 · utility

0Cited by
1References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 22, 2015
Grant dateSep 5, 2017
Priority date
Expiry dateOct 29, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2400/00
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates to a composition for detecting the undifferentiated human pluripotent stem cells comprising an agent useful for measuring the level of Desmoglein 2 (Dsg 2) mRNA or the protein thereof, a kit for detecting the undifferentiated human pluripotent stem cells comprising the said composition, a method for detecting the undifferentiated human pluripotent stem cells containing the step of measuring the level of Desmoglein 2 mRNA or the protein thereof, a method for evaluating the differentiation of human pluripotent stem cells and thereafter for separating the undifferentiated human pluripotent stem cells, a method for reducing the undifferentiated status of human pluripotent stem cells by inhibiting the expression or activation of Desmoglein 2, and a monoclonal antibody binding specifically to human Desmoglein 2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.